Back to announcement
20260512_KAEF_Pemanggilan RUPS_32090824_lamp3.pdf
RUPS notice Text extracted KAEFSource file signed link, expires in 15 minutes
Extracted text 7
Page 1
NOTICE TO THE
GENERAL MEETING OF SHAREHOLDERS OF 2025
PT KIMIA FARMA (PERSERO) Tbk
The Board of Directors of PT Kimia Farma Tbk (the “Company”) hereby announces
the invitation to the General Meeting of Shareholders of the Company for the year
2025 (hereinafter referred to as the “MEETING”), which will be convened on:
Day, Date : Wednesday, June 3, 2026
Time : 14.00 WIB (2 PM) until completion
Link to : Access the KSEI Electronic General Meeting System (eASY.KSEI)
attend the via the link: https://akses.ksei.co.id/ provided by KSEI
Meeting
In connection with the convening of the MEETING to be held electronically (e-GMS)
as referred to in the Financial Services Authority Regulation (POJK) No.
15/POJK.04/2020 concerning the Planning and Implementation of General Meetings
of Shareholders of Public Companies, and POJK No. 14 of 2025 concerning the
Electronic Implementation of General Meetings of Shareholders, Bondholders, and
Sukukholders, the Meeting will be conducted electronically through the e-GMS system
provided by PT Kustodian Sentral Efek Indonesia (“KSEI”), namely eASY.KSEI. The
Chairperson of the Meeting, Notary, as well as Supporting Professionals and
Institutions will coordinate the electronic implementation of the Meeting from Indonesia
Health Learning Institute, Jl. Cipinang Cimpedak I No. 36, East Jakarta.
The MEETING will be conducted with the following agendas:
1. Approval of the Company’s Annual Report for Fiscal Year 2025 and
Ratification of the Company’s Consolidated Financial Statements for Fiscal
Year 2025, the Board of Commissioners’ Supervisory Duties Report for Fiscal
Year 2025, as well as Ratification of the Report on the Implementation of the
Micro and Small Business Funding Program (Program Pendanaan Usaha
Mikro dan Usaha Kecil/PUMK) for Fiscal Year 2025, including an explanation
of the Company’s financial condition resulting from the restatement of the
Fiscal Year 2023 Financial Statements audited by KAP Hendrawinata, Hanny,
Erwin & Sumargo pursuant to its report Number 00274/2.1127/AU.1/04/0797-
3/1/VI/2025 dated 17 June 2025, and the granting of full release and discharge
(volledig acquit et de charge) to the Board of Directors for the management
actions of the Company and to the Board of Commissioners for the
supervisory actions of the Company carried out during Fiscal Year 2025.
Brief description:
1. Pursuant to Article 12 paragraph (2) letter b in conjunction with Article 19 and Article 22
paragraph (2) of the Company's Articles of Association, as well as Law Number 40 of
2007 concerning Limited Liability Companies, as amended (the "Company Law"), it is
stipulated that:
1
Page 2
a) the Board of Directors shall submit the Annual Report to the General Meeting of
Shareholders (“GMS”) after it has been reviewed by the Board of
Commissioners;
b) the approval of the Annual Report, including the ratification of the financial
statements and the report on the Supervisory Duties of the Board of
Commissioners, shall be carried out by the GMS.
2. Article 33 paragraph (1) of the Regulation of the Minister of State-Owned Enterprises
Number PER-1/MBU/03/2023 of 2023 concerning Special Assignments and the Social
and Environmental Responsibility Program of State-Owned Enterprises (“MOE
Regulation 01/2023”) stipulates that the financial statements and the report on the
implementation of the SOE Social and Environmental Responsibility Program (TJSL
BUMN) shall form an integral part of the quarterly reports and annual performance
reports of SOEs, which shall be set out in a separate chapter.
3. Based on the restatement of the Company's Financial Statements for Fiscal Year 2023
by KAP Hendrawinata, Hanny, Erwin & Sumargo, as set forth in its report Number
00274/2.1127/AU.1/04/0797-3/1/VI/2025 dated 17 June 2025.
2. Determination of the Salary/Honorarium, including Facilities and Allowances
for Fiscal Year 2026, as well as Performance-Based Remuneration for Fiscal
Year 2025 for the Management of the Company.
Brief description:
Pursuant to the Company’s Articles of Association, the Salary/Honorarium, Allowances and
Facilities of the Board of Commissioners and the Board of Directors of the Company, as
well as tantiem, must be resolved by the General Meeting of Shareholders (“GMS”).
3. Determination of the Public Accountant and/or Public Accounting Firm to
Audit the Company’s Consolidated Financial Statements and the Financial
Statements of the PUMK Program for Fiscal Year 2026.
Brief description:
Pursuant to Article 22 of the Company’s Articles of Association and Article 59 paragraph
(1) of Financial Services Authority Regulation Number 15/POJK.04/2020 concerning the
Planning and Conduct of General Meetings of Shareholders of Public Companies, the
appointment and dismissal of a Public Accountant and/or Public Accounting Firm that will
provide audit services on annual historical financial information must be resolved at the
General Meeting of Shareholders (“GMS”) of the Public Company by taking into
consideration the proposal of the Board of Commissioners.
4. Delegation of Authority to Approve the Company's Long-Term Plan (Rencana
Jangka Panjang Perusahaan or "RJPP") for the 2026–2030 Period and the
Company's Work Plan and Budget (Rencana Kerja dan Anggaran Perusahaan
or "RKAP") for Fiscal Year 2027, including any amendments thereto, from the
General Meeting of Shareholders ("GMS") to a party designated by the GMS.
Brief description:
Based on Article 17 paragraph (3) of the Company's Articles of Association concerning the
Company's Long-Term Plan (RJPP) and Article 18 paragraph (2) concerning the
Company's Work Plan and Budget (RKAP), it is stipulated that the RJPP and RKAP shall
be approved by the GMS.
2
Page 3
5. Report on the Implementation of the Conversion of Mandatory Convertible
Bonds (Obligasi Wajib Konversi/OWK) into shares in the context of increasing
the Company’s capital, as well as approval for the granting of authority to the
Company’s Board of Commissioners to declare the amount of the increase in
issued and paid-up capital.
Brief description:
Pursuant to Article 41 paragraphs (1) and (2) of Law Number 40 of 2007 concerning Limited
Liability Companies, it is stipulated as follows:
(1) Any increase in the Company’s capital shall be carried out based on the approval of
the GMS.
(2) The GMS may delegate authority to the Board of Commissioners to approve the
implementation of the GMS resolution as referred to in paragraph (1) for a period of no
longer than 1 (one) year.
6. Report on the Implementation of the Transfer/Disposal and Write-Off of the
Company’s Assets representing more than 50% of the Company’s net assets,
as approved in the Extraordinary General Meeting of Shareholders (“EGMS”)
of the Company dated 3 November 2025.
Brief description:
The Company has obtained approval from the Extraordinary General Meeting of
Shareholders (“EGMS”) held on 3 November 2025 to carry out the Transfer/Disposition and
Write-Off of the Company’s Assets representing more than 50% of the Company’s net
assets for the Company’s purposes, which shall be conducted in the form of the sale of 38
(thirty-eight) Company assets consisting of land and buildings, namely:
a. 1 (one) land asset located in Cikarang with a value of Rp347 billion to PT Bio Farma
(Persero), being the Company’s main shareholder with ownership of 89.82%, and
therefore constituting an affiliated party.
b. 37 (thirty-seven) other land and building assets to be disposed of through auction at the
State Assets and Auction Service Office (Kantor Pelayanan Kekayaan Negara dan
Lelang/KPKNL), which is planned to be conducted during the period from 2026 to 2029.
The Company needs to report that, as of the date hereof, the transaction for the
transfer/disposal and write-off of the Company's assets has not yet been implemented and
will be carried out in compliance with the prevailing laws and regulations, including Financial
Services Authority Regulation No. 42/POJK.04/2020 concerning Affiliated Transactions
and Conflict of Interest Transactions and Financial Services Authority Regulation No.
17/POJK.04/2020 concerning Material Transactions and Changes in Business Activities.
7. Changes in the Composition of the Company’s Management.
Brief description:
Referring to the Company’s Articles of Association, the Board of Commissioners and the
Board of Directors shall be appointed and dismissed by the GMS.
3
Page 4
Notes:
1. This announcement shall serve as the official invitation to the MEETING for the
Company’s Shareholders; therefore, the Board of Directors of the Company will
not send a separate invitation to the Shareholders.
2. The Shareholders entitled to attend and vote electronically at the Meeting are
those whose names are recorded in the Company’s Shareholders Register
(“DPS”) and/or the owners of the Company’s shares in securities sub-accounts at
KSEI as of the closing of trading on the Indonesia Stock Exchange on Monday,
May 11, 2026.
3. As of the date of this announcement, the Company has made available the
materials for each Agenda of the MEETING, which may be downloaded through
the Company’s website at www.kimiafarma.co.id.
4. Shareholders who wish to grant electronic proxy authorization for the MEETING
through the eASY.KSEI application must take note of the following matters:
a. Registration Process
(i) Local individual shareholders who have not submitted a declaration of
attendance or proxy authorization through the eASY.KSEI application
within the deadline stated in item 2 and wish to attend The MEETING
electronically must complete their attendance registration in the
eASY.KSEI application on the date of the Meeting until the electronic
registration period is closed by the Company.
(ii) Local individual shareholders who have submitted a declaration of
attendance but have not cast at least one vote for any of the MEETING’s
agenda items in the eASY.KSEI application within the deadline stated in
item 2 and wish to attend the Meeting electronically must complete their
attendance registration in the eASY.KSEI application on the date of the
MEETING until the electronic registration period is closed by the
Company.
(iii) Shareholders who have granted a proxy to a proxyholder appointed by the
Company (Independent Representative) or an Individual Representative
but have not cast at least one vote for any of the MEETING’s agenda items
in the eASY.KSEI application within the deadline stated in item 2 must
ensure that the respective proxyholder completes the attendance
registration in the eASY.KSEI application on the date of the MEETING
until the electronic registration period is closed by the Company.
(iv) Shareholders who have granted a proxy to a participant/intermediary
proxyholder (Custodian Bank or Securities Company) and have cast their
votes through the eASY.KSEI application within the deadline stated in item
2 must ensure that the authorized representative registered in the
eASY.KSEI application completes the attendance registration in the
eASY.KSEI application on the date of the MEETING until the electronic
registration period is closed by the Company.
(v) Shareholders who have submitted a declaration of attendance or granted
a proxy to a proxyholder appointed by the Company (Independent
Representative) or an Individual Representative and have cast at least
one or all votes for the MEETING’s agenda items through the eASY.KSEI
application within the deadline stated in item 2 are not required to
4
Page 5
complete electronic attendance registration in the eASY.KSEI application
on the date of the MEETING. Their share ownership will automatically be
counted toward the meeting quorum, and the votes previously submitted
will automatically be counted in the MEETING’s voting process.
(vi) Any delay or failure to complete the electronic registration process as
referred to in points (i) through (iv), for any reason whatsoever, will result
in the Shareholder or its proxyholder being unable to attend the MEETING
electronically, and such share ownership will not be counted toward the
quorum of the MEETING.
b. Process for Submitting Questions and/or Opinions Electronically
(i) Shareholders or their proxyholders shall have three (3) opportunities to
submit questions and/or opinions during each discussion session for every
MEETING agenda item. Questions and/or opinions for each agenda item
of the Meeting may be submitted in writing by the Shareholder or
proxyholder using the chat feature in the ‘Electronic Opinions’ column
available on the E-Meeting Hall screen within the eASY.KSEI application.
Questions and/or opinions may be submitted while the MEETING status
in the ‘General Meeting Flow Text’ column displays “Discussion started for
agenda item No. […]”.
(ii) The determination of the discussion mechanism for each agenda item of
the MEETING through written means via the E-Meeting Hall screen in the
eASY.KSEI application shall be at the discretion of each Company and
will be stipulated in the Company’s Rules of Conduct for the MEETING as
provided in the eASY.KSEI application.
(iii) Proxyholders attending electronically who wish to submit questions and/or
opinions on behalf of the Shareholders they represent during the
discussion session of each MEETING agenda item must state the name
of the Shareholder and the number of shares owned, followed by the
relevant question or opinion.
c. Electronic Voting Process
(i) The electronic voting process shall be conducted through the eASY.KSEI
application under the E-Meeting Hall menu, sub-menu Live Broadcasting.
(ii) Shareholders who attend in person electronically or are represented by
their proxyholders but have not yet cast their votes for any MEETING
agenda item as referred to in item 4 letter a points (i)–(iv), shall have the
opportunity to cast their votes during the voting period opened by the
Company through the E-Meeting Hall screen in the eASY.KSEI
application. When the electronic voting period for each Meeting agenda
item begins, the system will automatically initiate the voting countdown
(voting time) with a maximum duration of five (5) minutes. During the
electronic voting process, the status “Voting for agenda item No […] has
started” will appear in the General Meeting Flow Text column. If a
Shareholder or its proxyholder does not cast a vote for a particular
Meeting agenda item until the Meeting status shown in the General
Meeting Flow Text column changes to “Voting for agenda item No […] has
ended,” such Shareholder shall be deemed to have cast an Abstain vote
for the relevant agenda item.
5
Page 6
(iii) The voting time during the electronic voting process constitutes the
standard period determined by the eASY.KSEI application. Each
Company may set its own policy regarding the duration of electronic voting
for each MEETING agenda item (with a maximum of five (5) minutes per
item), which will be stipulated in the Company’s Rules of Conduct for the
MEETING through the eASY.KSEI application.
d. Viewing the Meeting via the GMS Broadcast
(i) Shareholders or their proxyholders who have been registered in the
eASY.KSEI application no later than the deadline stated in item 2 may
view the ongoing Meeting via a Zoom Webinar by accessing the GMS
Broadcast submenu under the eASY.KSEI menu available on the AKSes
facility (https://akses.ksei.co.id/).
(ii) The GMS Broadcast accommodates up to 500 participants, and
participation will be determined on a first-come, first-served basis.
Shareholders or their proxyholders who are unable to view the Meeting
through the GMS Broadcast shall still be deemed to have validly attended
the Meeting electronically, and their share ownership and votes will be
counted, provided that they have been registered in the eASY.KSEI
application in accordance with the provisions set out in item 4 letter a
points (i)–(vi).
(iii) Shareholders or their proxyholders who only view the Meeting through the
GMS Broadcast but are not electronically registered in the eASY.KSEI
application as stipulated in item 4 letter a points (i)–(vi) shall be deemed
not to have validly attended the Meeting, and their attendance will not be
counted toward the quorum.
(iv) Shareholders or their proxyholders viewing the Meeting through the GMS
Broadcast will have access to the raise hand feature, which may be used
to submit questions and/or opinions during the discussion session of each
Meeting agenda item. If the Company permits and activates the allow to
talk feature, Shareholders or their proxyholders may deliver their
questions and/or opinions verbally. The determination of the discussion
mechanism for each Meeting agenda item using the allow to talk feature
within the GMS Broadcast shall be at the discretion of each Company and
will be stipulated in the Company’s Rules of Conduct for the Meeting
through the eASY.KSEI application.
(v) For the best experience in using the eASY.KSEI application and/or GMS
Broadcast, Shareholders or their proxyholders are advised to use the
Mozilla Firefox browser.
5. The Notary, assisted by the Share Registrar, will verify and count the votes for
each agenda item of the MEETING in every decision-making process, including
the votes submitted by the Shareholders through the eASY.KSEI system as
referred to in item 4 letter c points (i)–(iii) above, as well as those cast during the
MEETING.
6. The Company recommends that Shareholders entitled to attend the Meeting
whose shares are held in collective custody at KSEI register their attendance
ELECTRONICALLY through the KSEI System (eASY.KSEI) via the link
https://akses.ksei.co.id/ provided by KSEI. The electronic registration period will
6
Page 7
open as of the date of this MEETING invitation and will close no later than 1:30
p.m. Western Indonesia Time (WIB) on the day of the MEETING.
7. Guidelines for registration, usage, and further information regarding eASY.KSEI
may be accessed on the Company’s website at www.kimiafarma.co.id and/or at
https://akses.ksei.co.id/.
8. In the event that a Shareholder wishes to attend the MEETING outside the
eASY.KSEI mechanism, the Shareholder may download the proxy form available
on the Company’s website at www.kimiafarma.co.id.
9. Shareholders who have granted proxy authorization as referred to in item 4 above
may submit questions regarding the Meeting’s agenda items via email to the
Company at corsec@kimiafarma.co.id, with a copy to DM@datindo.com. Such
questions will be presented during the Meeting by the appointed proxyholder and
recorded in the Minutes of MEETING prepared by the Notary. The responses to
these questions will be sent to the Shareholder’s email no later than three (3)
working days after the MEETING.
10. To ensure proper organization and orderly conduct of the MEETING,
Shareholders or their authorized proxyholders are respectfully requested to
complete attendance registration no later than thirty (30) minutes before the
MEETING begins. Registration will be closed at 1:30 p.m. Western Indonesia Time
(WIB).
Jakarta, May 12, 2026
PT Kimia Farma (Persero) Tbk
Board of Directors
7
Names mentioned 7 people and organisations named in the text · linked when the evidence is strong
unresolved
org
Financial Services Authority
p.1 ×4
unresolved
org
PT Kustodian Sentral Efek Indonesia
p.1
unresolved
org
Hendrawinata
p.1 ×2
unresolved
org
Minister of State-Owned Enterprises Number PER-
p.2
unresolved
org
Indonesia Stock Exchange
p.4
Extraction attempts how the parser did, and what it refused
Nothing structured was extracted from this document — the attempts below say why.
No extraction attempted yet.